<VariationArchive VariationID="2904997" VariationName="NM_000540.3(RYR1):c.6469del (p.Glu2157fs)" VariationType="Deletion" Accession="VCV002904997" Version="3" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-07-29" DateCreated="2024-02-20" MostRecentSubmission="2024-06-02">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3069191" VariationID="2904997">
      <GeneList>
        <Gene Symbol="RYR1" FullName="ryanodine receptor 1" GeneID="6261" HGNC_ID="HGNC:10483" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19q13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="38433691" stop="38587564" display_start="38433691" display_stop="38587564" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="38924339" stop="39078203" display_start="38924339" display_stop="39078203" Strand="+" />
          </Location>
          <OMIM>180901</OMIM>
          <Haploinsufficiency last_evaluated="2015-11-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RYR1">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2015-11-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RYR1">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000540.3(RYR1):c.6469del (p.Glu2157fs)</Name>
      <CanonicalSPDI>NC_000019.10:38494545:G:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19q13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="38494546" stop="38494546" display_start="38494546" display_stop="38494546" variantLength="1" positionVCF="38494545" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="38985186" stop="38985186" display_start="38985186" display_stop="38985186" variantLength="1" positionVCF="38985185" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>E2157fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.38494546del" Assembly="GRCh38">
            <Expression>NC_000019.10:g.38494546del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.38985186del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.38985186del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008866.1" sequenceAccession="NG_008866" sequenceVersion="1" change="g.65847del">
            <Expression>NG_008866.1:g.65847del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000540.3" sequenceAccession="NM_000540" sequenceVersion="3" change="c.6469del" MANESelect="true">
            <Expression>NM_000540.3:c.6469del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000531.2" sequenceAccession="NP_000531" sequenceVersion="2" change="p.Glu2157fs">
            <Expression>NP_000531.2:p.Glu2157fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001042723.2" sequenceAccession="NM_001042723" sequenceVersion="2" change="c.6469del">
            <Expression>NM_001042723.2:c.6469del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001036188.1" sequenceAccession="NP_001036188" sequenceVersion="1" change="p.Glu2157fs">
            <Expression>NP_001036188.1:p.Glu2157fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_766" sequenceAccession="LRG_766">
            <Expression>LRG_766:g.65847del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_766t1" sequenceAccession="LRG_766t1">
            <Expression>LRG_766t1:c.6469del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_766p1" sequenceAccession="LRG_766p1" change="p.Glu2157Serfs">
            <Expression>LRG_766p1:p.Glu2157Serfs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000540.3(RYR1):c.6469del (p.Glu2157fs) AND RYR1-related disorder" Accession="RCV003756959" Version="1">
        <ClassifiedConditionList TraitSetID="33623">
          <ClassifiedCondition DB="MedGen" ID="CN239331">RYR1-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-12-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000540.3(RYR1):c.6469del (p.Glu2157fs) AND Malignant hyperthermia, susceptibility to, 1" Accession="RCV004005879" Version="2">
        <ClassifiedConditionList TraitSetID="3539">
          <ClassifiedCondition DB="MedGen" ID="C2930980">Malignant hyperthermia, susceptibility to, 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-04" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000540.3(RYR1):c.6469del (p.Glu2157fs) AND Congenital multicore myopathy with external ophthalmoplegia" Accession="RCV004556877" Version="1">
        <ClassifiedConditionList TraitSetID="3543">
          <ClassifiedCondition DB="MedGen" ID="C1850674">Congenital multicore myopathy with external ophthalmoplegia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-07-19" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-05-04" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2024-02-20" MostRecentSubmission="2024-06-02">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(1); Likely pathogenic(1); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">20583297</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20839240</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23919265</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28818389</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(1); Likely pathogenic(1); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2024-04-19">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="33623" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36528" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">RYR1-Related Disorders</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">RYR1-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">RYR1-related condition</ElementValue>
              </Name>
              <XRef ID="CN239331" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3539" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2639" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Malignant hyperthermia, susceptibility to, 1</ElementValue>
                <XRef ID="MONDO:0007783" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Anesthesia related hyperthermia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Malignant hyperpyrexia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fulminating hyperpyrexia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pharmacogenic myopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Malignant hyperthermia suceptibility 1</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MHS1</ElementValue>
                <XRef Type="MIM" ID="145600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Malignant hyperthermia susceptibility (MHS) is a pharmacogenetic disorder of skeletal muscle calcium regulation associated with uncontrolled skeletal muscle hypermetabolism. Manifestations of malignant hyperthermia (MH) are precipitated by certain volatile anesthetics (i.e., halothane, isoflurane, sevoflurane, desflurane, enflurane), either alone or in conjunction with a depolarizing muscle relaxant (specifically, succinylcholine). The triggering substances cause uncontrolled release of calcium from the sarcoplasmic reticulum and may promote entry of extracellular calcium into the myoplasm, causing contracture of skeletal muscles, glycogenolysis, and increased cellular metabolism, resulting in production of heat and excess lactate. Affected individuals experience acidosis, hypercapnia, tachycardia, hyperthermia, muscle rigidity, compartment syndrome, rhabdomyolysis with subsequent increase in serum creatine kinase (CK) concentration, hyperkalemia with a risk for cardiac arrhythmia or even cardiac arrest, and myoglobinuria with a risk for renal failure. In nearly all cases, the first manifestations of MH (tachycardia and tachypnea) occur in the operating room; however, MH may also occur in the early postoperative period. There is mounting evidence that some individuals with MHS will also develop MH with exercise and/or on exposure to hot environments. Without proper and prompt treatment with dantrolene sodium, mortality is extremely high.</Attribute>
                <XRef ID="NBK1146" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3363" />
                <XRef ID="3363" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Pharmacogenetic</Attribute>
              </AttributeSet>
              <Citation Type="general" Abbrev="EMHG, 2018">
                <ID Source="PubMed">33131754</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301325</ID>
                <ID Source="BookShelf">NBK1146</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="pmc">3110041</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Sei et al., 2004">
                <ID Source="PubMed">14870754</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2013">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_MalignantHyperthermia-enPro649.pdf</URL>
                <CitationText>Orphanet Emergency Guidelines: Malignant hyperthermia</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/PDFLibrary/Malignant-Hyperthermia.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, RYR1 and CACNA1S Pathogenic Variants (Malignant Hyperthermia), 2019</CitationText>
              </Citation>
              <XRef ID="423" DB="Orphanet" />
              <XRef ID="C2930980" DB="MedGen" />
              <XRef ID="MONDO:0007783" DB="MONDO" />
              <XRef Type="MIM" ID="145600" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3543" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3205" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital multicore myopathy with external ophthalmoplegia</ElementValue>
                <XRef ID="MONDO:0009712" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MULTICORE MYOPATHY</ElementValue>
                <XRef Type="MIM" ID="255320" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Minicore myopathy with external ophthalmoplegia</ElementValue>
                <XRef ID="C150608" DB="NCI" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital myopathy 1B, autosomal recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Minicore myopathy</ElementValue>
                <XRef ID="HP:0003789" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Multicore myopathy with external ophthalmoplegia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Multiminicore disease with external ophthalmoplegia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CMYO1B</ElementValue>
                <XRef Type="MIM" ID="255320" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10316" />
                <XRef ID="10316" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">RYR1-Related Multiminicore Disease</Attribute>
              </AttributeSet>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">22009146</ID>
              </Citation>
              <XRef ID="598" DB="Orphanet" />
              <XRef ID="98905" DB="Orphanet" />
              <XRef ID="C1850674" DB="MedGen" />
              <XRef ID="MONDO:0009712" DB="MONDO" />
              <XRef Type="MIM" ID="255320" DB="OMIM" />
              <XRef Type="primary" ID="HP:0003789" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0003804" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8321880" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="9402035|MedGen:CN239331" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004532776" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20583297</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20839240</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23919265</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28818389</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with RYR1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Glu2157Serfs*22) in the RYR1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RYR1 are known to be pathogenic (PMID: 20583297, 20839240, 23919265, 28818389).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RYR1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.38985186del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN239331" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9016589" SubmissionDate="2024-04-16" DateLastUpdated="2024-04-20" DateCreated="2024-04-20">
        <ClinVarSubmissionID localKey="729476|MONDO:0007783" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004827009" DateUpdated="2024-04-20" DateCreated="2024-04-20" Type="SCV" Version="1" SubmitterName="All of Us Research Program, National Institutes of Health" OrgID="509529" OrganizationCategory="consortium" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain Significance</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>108544</NumberTested>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RYR1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.38985186del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0007783" />
          </Trait>
        </TraitSet>
        <Comment>This study involves interpretation of variants in research participants for the purpose of population health screening. Participant phenotype was not available at the time of variant classification. Additional details can be found in publication PMID: 35346344, PMCID: PMC8962531</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB14382316</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9794307" SubmissionDate="2024-05-06" DateLastUpdated="2024-06-02" DateCreated="2024-06-02">
        <ClinVarSubmissionID localKey="NM_000540.3:c.6469del|Congenital myopathy 1B, autosomal recessive" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005045726" DateUpdated="2024-06-02" DateCreated="2024-06-02" Type="SCV" Version="1" SubmitterName="Human Genome Sequencing Center Clinical Lab, Baylor College of Medicine" OrgID="500199" OrganizationCategory="laboratory" OrgAbbreviation="HGSC-CL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RYR1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000540.3:c.6469del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Congenital myopathy 1B, autosomal recessive</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14428355</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8321880" TraitType="Disease" MappingType="XRef" MappingValue="CN239331" MappingRef="MedGen">
        <MedGen CUI="CN239331" Name="RYR1-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9794307" TraitType="Disease" MappingType="Name" MappingValue="Congenital myopathy 1B, autosomal recessive" MappingRef="Preferred">
        <MedGen CUI="C1850674" Name="Congenital multicore myopathy with external ophthalmoplegia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9016589" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0007783" MappingRef="MONDO">
        <MedGen CUI="C2930980" Name="Malignant hyperthermia, susceptibility to, 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

